Peter Ray
About Peter Ray
Peter Ray is a drug designer with extensive experience in the pharmaceutical industry, currently working at Exscientia Ltd and the University of Dundee. He has held various roles at notable companies and institutions, focusing on optimizing drug discovery processes using AI technology.
Work at Exscientia
Peter Ray has been employed at Exscientia Ltd as a Drug Designer since 2018. In this role, he focuses on utilizing artificial intelligence systems to enhance productivity in the pharmaceutical industry. His work emphasizes rapid cycle times for drug target discovery, aiming to identify small molecule clinical candidates with a target of less than 500 molecules.
Education and Expertise
Peter Ray holds a Bachelor of Science degree from the University of Cape Town, where he studied Physics, Organic Chemistry, Biochemistry, Statistics, and Chemistry from 1992 to 1995. He furthered his education with a Master of Science in Organic Chemistry from the same university from 1995 to 1997. He obtained a Doctor of Philosophy in Organic Chemistry from the University of Liverpool from 1997 to 2000.
Background
Peter Ray has a diverse professional background in drug design and optimization. He worked at Merck as a Project Manager from 2009 to 2011 and held positions at Schering-Plough Research Institute as a Lead Optimization Project Leader and Lead Chemist from 2008 to 2009. His experience also includes roles at UCB as a Group Leader in 2011, Organon as a Lead Optimization Project Leader and Lead Chemist from 2003 to 2008, and as a Lecturer and Post-doc Researcher at the University of Nottingham in 2000.
Current Role at University of Dundee
Since 2011, Peter Ray has served as the DDU TB Program Lead at the University of Dundee. In this capacity, he contributes to research and initiatives focused on tuberculosis, leveraging his extensive background in drug design and optimization to advance the program's objectives.